ENTERPRISE THERAPEUTICS LTD has a total of 50 patent applications. It decreased the IP activity by 64.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are INVENTISBIO INC, ADT PHARMACEUTICALS LLC and ARBUTUS BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 12 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 3 | |
#5 | Australia | 2 | |
#6 | Brazil | 2 | |
#7 | Canada | 2 | |
#8 | Israel | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Taiwan | 2 | |
#11 | China | 1 | |
#12 | Colombia | 1 | |
#13 | Costa Rica | 1 | |
#14 | Mexico | 1 | |
#15 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mccarthy Clive | 26 |
#2 | Schofield Thomas Beauregard | 21 |
#3 | Hay Duncan Alexander | 21 |
#4 | Hargrave Jonathan David | 17 |
#5 | Went Naomi | 15 |
#6 | Collingwood Stephen | 14 |
#7 | Stimson Christopher | 12 |
#8 | Smith Matthew | 11 |
#9 | Walker Edward | 11 |
#10 | Ingram Peter | 11 |
Publication | Filing date | Title |
---|---|---|
WO2021014166A1 | Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions | |
WO2020249957A1 | Compounds for treating respiratory disease | |
GB202005739D0 | Compounds | |
GB201917691D0 | Compounds for treating respiratory disease | |
GB201910666D0 | Novel form of compounds | |
GB201910664D0 | Novel forms of compound | |
GB201910665D0 | Novel form of compounds | |
GB201910607D0 | Compounds | |
GB201910608D0 | Compounds | |
GB201908453D0 | Compounds for treating respiratory disease | |
GB201908451D0 | Compounds for treating respiratory disease | |
GB201808093D0 | Compounds | |
GB201801355D0 | Compounds | |
CN110214141A | Benzodiazole compound as ENaC inhibitor | |
GB201717051D0 | Compounds | |
US2019233402A1 | Compounds |